U S PHYSICAL THERAPY INC /NV Payments for (Proceeds from) Limited Partnership
U S PHYSICAL THERAPY INC /NV (USPH) reported Payments for (Proceeds from) Limited Partnership of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromLimitedPartnership · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for the quarter ending 2026-06-30 was $0.00.
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for the quarter ending 2026-03-31 was $0.00.
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for the quarter ending 2025-06-30 was $0.00.
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for the quarter ending 2025-03-31 was -$700.00K.
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for fiscal 2025 was -$700.00K.
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for fiscal 2024 was $0.00.
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for fiscal 2023 was $0.00.
- U S PHYSICAL THERAPY INC /NV payments for (proceeds from) limited partnership for fiscal 2022 was -$373.00K.
| Period end | Payments for (Proceeds from) Limited Partnership 3 month | Payments for (Proceeds from) Limited Partnership 6 month | Payments for (Proceeds from) Limited Partnership 9 month | Payments for (Proceeds from) Limited Partnership 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | -$700.00K 10-K · filed 2026-02-27 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$700.00K 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | -$700.00K 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $237.00K derived: sum of 2 quarters · filed 2026-02-27 | $107.00K derived: sum of 3 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 |
| 2023-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $100.00K derived: sum of 2 quarters · filed 2023-11-08 | -$7.00K 10-Q · filed 2023-11-08 | $360.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$237.00K 10-Q · filed 2023-08-09 | $130.00K derived: sum of 3 quarters · filed 2025-03-03 | $130.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$107.00K 10-Q · filed 2023-05-05 | $260.00K derived: sum of 2 quarters · filed 2025-03-03 | $260.00K derived: sum of 3 quarters · filed 2025-03-03 | -$476.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $367.00K derived: sum of 2 quarters · filed 2025-03-03 | -$369.00K derived: sum of 3 quarters · filed 2025-03-03 | -$373.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$736.00K derived: sum of 2 quarters · filed 2023-11-08 | -$740.00K 10-Q · filed 2023-11-08 | -$879.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$736.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$740.00K 10-Q · filed 2023-08-09 | -$879.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.18M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-05 | -$143.00K derived: sum of 2 quarters · filed 2024-02-29 | -$447.00K derived: sum of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$443.00K derived: sum of 2 quarters · filed 2024-02-29 | -$275.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$136.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $168.00K 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | -$839.00K 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |